LXP-2311

N/A

Report date: 2025/02/25 14:52:25
First In Class

Base Information

Drug NameLXP-2311
Drug Alias NameLXP2311LXP-2311
ClassificationOther
Mechanisms of ActionBeta-2 adrenergic receptor agonistsAcetylcholine modulators
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLexenpharm (Suzhou) Litmited
China Registration ClassN/A

Develop Information

Active CompaniesLexenpharm (Suzhou) LitmitedBeijing Sunshine Novo Pharmaceutical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A